Evotec SE (EVO) Other Non-Current Liabilities (2020 - 2026)
Evotec SE's (EVO) quarterly Other Non-Current Liabilities came in at $1.6 million in Q2 2026, up 17.64% year-over-year from $1.3 million in Q2 2025, and down 0.72% quarter-over-quarter from $1.6 million in Q1 2026.
Analysis
Evotec SE (EVO) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Evotec SE has disclosed Other Non-Current Liabilities across 7 years of filings, most recently posting $1.6 million for Q2 2026.
- In Q2 2026, Other Non-Current Liabilities rose 17.64% year-over-year to $1.6 million; the TTM figure through Jun 2026 stood at $1.6 million (up 17.64% YoY), while the FY2025 annual figure was $1.9 million, up 36.45% from the prior year.
- Other Non-Current Liabilities came in at $1.6 million for Q2 2026 at Evotec SE, down from $1.6 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $25.1 million in Q3 2024 to a low of -$404414.5 in Q2 2022.
- Average Other Non-Current Liabilities over 5 years is $2.9 million, with a median of $1.3 million recorded in 2025.
- Year-over-year, Other Non-Current Liabilities jumped 340.45% in 2023 and retreated 6.05% in 2024.
- Over 5 years, Other Non-Current Liabilities stood at $996781.7 in 2022, then jumped by 49.71% to $1.5 million in 2023, then retreated by 6.05% to $1.4 million in 2024, then soared by 42.39% to $2.0 million in 2025, then decreased by 22.15% to $1.6 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $1.6 million in Q2 2026, $1.6 million in Q1 2026, and $2.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.55 Mn |
| Mar 31, 2026 | 1.57 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Jun 30, 2025 | 1.32 Mn |
| Mar 31, 2025 | 1.30 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Sep 30, 2024 | 25.12 Mn |
| Dec 31, 2023 | 1.49 Mn |
| Jun 30, 2023 | 972,409.48 |
| Dec 31, 2022 | 996,781.68 |
| Sep 30, 2022 | 469,855.84 |
| Jun 30, 2022 | -404,414.48 |
| Mar 31, 2022 | 524,131.71 |
| Dec 31, 2021 | 534,234.43 |
| Sep 30, 2021 | 241,753.90 |
| Dec 31, 2020 | 244,419.42 |